SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
FORM 8-K/A
AMENDMENT NO. 1 TO
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): MAY 15, 2001
BIOTRANSPLANT INCORPORATED
(Exact name of registrant as specified in its charter)
DELAWARE 000-28324 04-3119555
----------------------------------- ----------------------------------- -------------------
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation) Identification No.)
Building 75, Third Avenue
Charlestown Navy Yard
Charlestown, MA 02129
------------------------------------- ------------------------------
(Address of principal executive (Zip Code)
offices)
Registrant's telephone number, including area code: (617) 241-5200
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
This Amendment No. 1 on Form 8-K/A is filed for the purpose of filing
the financial statements of Eligix, Inc. ("Eligix") required by Item 7(a) and
the pro forma financial information required by Item 7(b).
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) Financial Statements of Businesses Acquired.
The financial statements of Eligix required by this item are included
as Exhibit 99.2 to this Amendment No. 1 to Current Report on Form 8-K/A and
incorporated herein by reference.
(b) Pro Forma Financial Information.
The pro forma financial information required by this item is included
as Exhibit 99.3 to this Amendment No. 1 to Current Report on Form 8-K/A and
incorporated herein by reference.
(c) Exhibits.
See Exhibit Index attached hereto.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
Date: June 26, 2001 BIOTRANSPLANT INCORPORATED
By: /s/ Richard V. Capasso
-----------------------------
Richard V. Capasso
Vice President, Finance and Treasurer
EXHIBIT INDEX
EXHIBIT NO. EXHIBIT
2.1 Agreement and Plan of Merger, dated as of December 8, 2000, by and among
BioTransplant Incorporated, BT/EL Acquisition Co. and Eligix, Inc.
(Incorporated herein by reference to Annex A to the Joint Proxy
Statement/Prospectus included in the Registrant's Registration Statement
on Form S-4 (File No. 333-53386)).
23.1 Consent of PricewaterhouseCoopers LLP.
99.1 Press Release dated May 16, 2001 (previously filed as Exhibit 99.1 to
the Registrant's Current Report on Form 8-K filed on May 25, 2001).
99.2 Financial Statements of Eligix, Inc.
99.3 Unaudited Pro Forma Financial Information of BioTransplant and Eligix.